| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |